48 results
8-K
EX-99.1
ARVN
Arvinas Inc
16 May 24
Regulation FD Disclosure
6:05am
the last dose. Advise females to inform their healthcare provider of a known or suspected pregnancy. Advise women not to breastfeed during IBRANCE
S-3ASR
ARVN
Arvinas Inc
8 Dec 23
Automatic shelf registration
9:16am
Capital, LLC(8)
Citadel CEMF Investments Ltd.(9)
Entities affiliated with Venrock(10)
RA Capital Healthcare Fund, L.P.(11)
Adage Capital Partners, L.P … of (i) 455,356 shares of common stock held by Venrock Healthcare Capital Partners EG, LP, (ii) 11,644 shares of common stock held by Venrock
8-K
EX-99.1
ARVN
Arvinas Inc
6 Dec 23
Regulation FD Disclosure
7:01am
IBRANCE treatment and for 3 months after the last dose. Advise females to inform their healthcare provider of a known or suspected pregnancy. Advise
8-K
EX-99.2
tlrv2da x3
6 Dec 23
Regulation FD Disclosure
7:01am
8-K
EX-10.2
izmtz wlc3yrf1wcdc
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
8-K
EX-10.1
qqvnvlo2i z7jgb
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
S-3ASR
EX-1.2
oo7lm3mfeg yap
7 Nov 23
Automatic shelf registration
5:24pm
8-K
EX-99.2
cvvjttu3uyuuwp9q
23 Oct 23
Regulation FD Disclosure
8:30am
8-K
EX-99.2
6wp6m1gf8cax
8 Jun 23
Regulation FD Disclosure
7:14am
8-K
rrb 8vrnu
8 Jun 23
Regulation FD Disclosure
7:14am
8-K
EX-99.1
d5zcm8c
8 Jun 23
Regulation FD Disclosure
7:14am
8-K
EX-99.1
javku16oews6
8 Dec 22
Regulation FD Disclosure
8:19am
8-K
EX-99.1
quab ay1l39dmh
22 Nov 22
Regulation FD Disclosure
5:26pm
8-K
EX-99.1
ddgmakqd7259g3l9wb
10 Dec 21
Regulation FD Disclosure
8:16am